The alterations of serum FGF-21 levels, metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapy

dc.contributor.authors	Akyol M, Alacacıoğlu A, Demir L, Küçükzeybek Y, Yıldız Y, Gümüş Z, Kara M, Salman T, Varol U, Taşkaynatan H, Oflazoğlu U, Bayoğlu İV, Tarhan MO
dc.date.accessioned	2020-02-27T08:26:12Z
dc.date.available	2020-02-27T08:26:12Z
dc.date.issued	2017
dc.identifier.citation	Akyol M, Alacacıoğlu A, Demir L, Küçükzeybek Y, Yıldız Y, Gümüş Z, Kara M, Salman T, Varol U, Taşkaynatan H, Oflazoğlu U, Bayoğlu İV, Tarhan MO (2017). The alterations of serum FGF-21 levels, metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapy. Cancer Biomarkers, 18(4), 449-441
dc.identifier.uri	https://doi.org/10.3233/CBM-161507
dc.identifier.uri	https://hdl.handle.net/20.500.12619/65750
dc.title	The alterations of serum FGF-21 levels, metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapy
dc.identifier.volume	18(4)
dc.identifier.startpage	441
dc.identifier.endpage	449
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Bayoğlu, İbrahim Vedat
dc.relation.journal	Cancer Biomarkers
dc.identifier.doi	10.3233/CBM-161507
dc.contributor.author	Bayoğlu, İbrahim Vedat